UFP Technologies

Valuation Analysis

About the Company

UFP Technologies en bref

UFP Technologies (UFPT) is currently trading at 208,81 € with a market capitalization of 1,6 Md €. The trailing P/E ratio stands at 27.28x, with a forward P/E of 20.47x. The 52-week range spans from 151,72 € to 239,92 €; the current price is 13% below the yearly high. Year-over-year revenue growth stands at +4.1%. The net profit margin stands at 11.27%.

💰 Dividende

UFP Technologies currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

2 analystes évaluent UFP Technologies (UFPT) au consensus : None. L'objectif de cours moyen est de 283,18 €, soit un potentiel de +35.62% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 252,20 € à 314,16 €.

UFP Technologies : la thèse d'investissement en détail

UFP Technologies (UFPT) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Revenue growth has slowed to just 4.1%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Short interest sits at 20.33% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

At a PEG of 3.8, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.

À surveiller

• The forward P/E of 20.47x is meaningfully below the trailing 27.28x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 35.62% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to market-like volatility, elevated short interest (20.33%).

Trading Data

Related Stocks in the Same Sector

Where can I buy UFP Technologies?

Compare top-rated brokers — low fees, trusted providers, fully regulated.